https://scholars.lib.ntu.edu.tw/handle/123456789/551886
Title: | Edoxaban versus warfarin in patients with atrial fibrillation | Authors: | Giugliano, Robert P Ruff, Christian T Braunwald, Eugene Murphy, Sabina A Wiviott, Stephen D Halperin, Jonathan L Waldo, Albert L Ezekowitz, Michael D Weitz, Jeffrey I Špinar, Jindřich Ruzyllo, Witold Ruda, Mikhail Koretsune, Yukihiro Betcher, Joshua Shi, Minggao Grip, Laura T Patel, Shirali P Patel, Indravadan Hanyok, James J Mercuri, Michele Antman, Elliott M FU-TIEN CHIANG |
Keywords: | FACTOR XA INHIBITOR; ORAL ANTICOAGULANTS; STROKE; PHARMACOKINETICS; METAANALYSIS; GENERATION; PREVENTION; SAFETY | Issue Date: | 28-Nov-2013 | Publisher: | MASSACHUSETTS MEDICAL SOC | Journal Volume: | 369 | Journal Issue: | 22 | Start page/Pages: | 2093 | Source: | The New England journal of medicine | Abstract: | Edoxaban is a direct oral factor Xa inhibitor with proven antithrombotic effects. The long-term efficacy and safety of edoxaban as compared with warfarin in patients with atrial fibrillation is not known. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/551886 | ISSN: | 0028-4793 | DOI: | 10.1056/NEJMoa1310907 |
Appears in Collections: | 醫學院附設醫院 (臺大醫院) |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.